What if you didn’t have to compromise?

Novela is a direct fed microbial (DFM) product for poultry. It is created from a unique and novel combination of multiple Bacillus subtilis strains selected from a highly scientific and intense strain selection process. Novela provides consistent proven results.

About Novela

  • Unique and novel combination of multiple Bacillus subtilis strains
  • Strains selected from a proprietary development process
  • Strains selected from animals fed today’s diets containing DDGS
  • Strains isolated from the gastrointestinal tract of high performing animals
  • A pellet stable formulation

Results of Novela

  • Encourages positive body weight gain and feed conversion for both large and small birds
  • Shows performance increases in both high health and health challenged flocks, based on trials conducted by United Animal Health
  • Works in diets that contain high levels of DDGS
  • Fosters growth performance with or without antibiotics in the diet
  • Grows on diverse substrates
  • Provides beneficial contributions to gut microflora

Request More Information


The information above does not constitute a medical claim, but instead are the results of our independent research trials. You should conduct your own tests to determine the suitability of our products for your own specific purposes. The information contained herein is based on our own research and to our knowledge is reliable. Statements contained herein should not be considered as, and do not constitute a warranty of any kind, expressed or implied, and no liability is accepted for the infringement of any patents.

Uncompromising Innovation.

Since 1956, United Animal Health has been committed to innovating animal nutrition, and that includes providing alternatives for producers to address the ever-changing needs of their customers.

In 2000, United Animal Health began the development of unique and proprietary enzymes. Six years later in 2006, we launched Enzyvia®, a company focused on enzymes. Enzyvia hired dedicated technical service and sales teams focused on the poultry industry.

By 2007, we could see where the future was going and made a major investment in microbial research and discovery by founding the Microbial Discovery Group (MDG). The vision of MDG was to develop innovative direct fed microbial technologies and establish a fully integrated approach to discovery, validation, manufacturing, and distribution of microbials.

In 2013, the dedicated teams of Enzyvia were brought back into United Animal Health to increase capabilities and opportunities for our partners.

With the basic research and basic manufacturing capabilities of Microbial Discovery Group and the knowledge of the animal nutrition industry and commercial research farms of United Animal Health, our capabilities and your opportunities are unmatched.

Our investments in a fermentation facility and pathogen lab ensure you are getting products that work. Each Bacillus strain is selected from our unique and proprietary process and isolated from high performing animals that are fed today’s diets. Each product is researched under commercial conditions and nothing goes to market until we are sure it does what we say.